AstraZeneca acquires Omniose
AstraZeneca has completed the acquisition of Omniose, a biotechnology firm specializing in vaccines against serious bacterial infections. This…
Nordic Life Science 1 source No second source matchedSearch and explore source-backed Nordic startup news, from funding and partnerships to the people building what comes next.
Looking for a story from the former Nordic Startup News site? Browse the restored archive. Updated Nov 20, 2026.